The National Heart, Lung, and Blood Institute (NHLBI) is strongly committed to supporting research aimed at preventing and treating heart, lung, and blood diseases and conditions and sleep disorders.
NHLBI-supported research has led to many advances in medical knowledge and care. For example, this research has helped doctors learn more about heart disease, its risk factors, and ways to prevent and treat the disease.
The NHLBI continues to support research aimed at learning more about heart disease, including coronary microvascular disease (MVD). For example, NHLBI-supported research includes studies that:
- Examine heart attack risks and recovery in young women (aged 18–55)
- Explore whether taking daily vitamin D or fish oil (omega-3) supplements reduces the risk of heart disease and other conditions
- Examine the role that hormones play in women's heart disease risk
Much of this research depends on the willingness of volunteers to take part in clinical trials. Clinical trials test new ways to prevent, diagnose, or treat various diseases and conditions.
For example, new treatments for a disease or condition (such as medicines, medical devices, surgeries, or procedures) are tested in volunteers who have the illness. Testing shows whether a treatment is safe and effective in humans before it is made available for widespread use.
By taking part in a clinical trial, you can gain access to new treatments before they're widely available. You also will have the support of a team of health care providers, who will likely monitor your health closely. Even if you don't directly benefit from the results of a clinical trial, the information gathered can help others and add to scientific knowledge.
If you volunteer for a clinical trial, the research will be explained to you in detail. You'll learn about treatments and tests you may receive, and the benefits and risks they may pose. You'll also be given a chance to ask questions about the research. This process is called informed consent.
If you agree to take part in the trial, you'll be asked to sign an informed consent form. This form is not a contract. You have the right to withdraw from a study at any time, for any reason. Also, you have the right to learn about new risks or findings that emerge during the trial.
For more information about clinical trials related to coronary microvascular disease, talk with your doctor. You also can visit the following Web sites to learn more about clinical research and to search for clinical trials:
Learn more about how to participate in a clinical trial.
Celebrating American Heart Month: NIH Advancing Heart Research02/07/2014
More than 100 members of the NIH community gathered at the NIH Clinical Center in Bethesda, MD, to raise awareness about women and heart disease. The crowd formed a giant human heart in honor of National Wear Red Day, which takes place each year on the first Friday of February. Speakers at the event included Dr. Francis Collins, director of the NIH; Dr. Gary H. Gibbons, director of the NHLBI; Dr. Griffin Rodgers, director of the National Institute of Diabetes and Digestive and Kidney Diseases; Dr. Janine Clayton, director of the NIH Office of Research on Women's Health; and Dr. John Gallin, director of the NIH Clinical Center. For more information about heart disease, visit the NHLBI web site. If you share this video on Twitter, please use #NationalWearRedDay.